%PDF-1.7 % 7 0 obj << /Type /Page /Parent 1 0 R /LastModified (D:20191213083123+01'00') /Resources 2 0 R /MediaBox [0.000000 0.000000 595.276000 841.890000] /CropBox [0.000000 0.000000 595.276000 841.890000] /BleedBox [0.000000 0.000000 595.276000 841.890000] /TrimBox [0.000000 0.000000 595.276000 841.890000] /ArtBox [0.000000 0.000000 595.276000 841.890000] /Contents 8 0 R /Rotate 0 /Group << /Type /Group /S /Transparency /CS /DeviceRGB >> /Annots [ 5 0 R 6 0 R ] /PZ 1 >> endobj 8 0 obj <> stream xVr0{ Ǝ{LqO--ٮKOܵ $Jʣ]VZ/1+ p}{B=Q] jOo ;'*Gr8_{Z)Azhh$p? p{eM.w2hzا#%q˯WpMpk8n%!.ߖzz186wiA,18=&D00dR!\f_k)U.XMX cHJCXz_(Vi @X> endobj 3 0 obj <> endobj 4 0 obj <> endobj 9 0 obj <> /Resources <> /ExtGState <> /Font <> /ProcSet [/PDF /Text /ImageB /ImageC /ImageI ] >> /Filter /FlateDecode /Length 901 >> stream x[O0+;xSb;4 VnӐ`4ihR (av_d;eke kvQ o$kuS8H&dr}^${l^*a횶|Z,޾{Hfp3O[uf)`E1|~p0w5eXpt6$;gHaT3k1Gnr2c "85B&`ƙwpp N ] HzUY7ͪo>ٌrT;W_d%Xϧ(**i9.=:PiuO;7 CfĈp$ќĜa}?!B7Dе~BH5~%6|ˬkdtwyE+6M". o“i7rdTky΂p}9oα6'FֽOWLw"Ὧ7ٵP]5 YА84tI$wE?.U>M?Bƴ(3Z`C-Q]R/( 5=wΚB2>Kw}3| xA0mrfT=n܍­[N%H:+_5/|7(ewL9> endobj 16 0 obj [250 0 0 0 0 0 0 0 0 0 0 564 0 333 250 0 500 500 500 500 500 0 0 500 500 500 0 0 0 0 0 0 921 0 0 0 722 0 556 722 722 0 0 0 0 889 0 0 556 0 0 556 611 0 0 0 0 0 611 0 0 0 0 0 0 444 500 444 500 444 0 500 500 278 0 500 278 778 500 500 0 0 333 389 278 500 500 722 500 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 ] endobj 15 0 obj <> endobj 13 0 obj <> endobj 12 0 obj <> endobj 11 0 obj <> stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (,K+F,p?h4ȹ׻*O_mS9ۜVy9}+TU}ZZ__Re|XZ]C9Ln63늳Td!al"qT! TL2NcLfr+O6ah[nYݤ)P*A\aj"ɣ:Yq>p2ُ9AU$oNlmYx]wFHA`ŰF>3k:ѶZ.:/\ZjK]7IJ5}Ӿ|* SirYzlDh7v E(ќCNmnޭlmG,q0 1H[RMnRmKK-Y$08FrxPvom/V|_hbywm3JBxY,JGߞ'5r=b+{]KOh%b&)at%dk\9ego+ERPjV>Yno‹@[v6F2%{| Fߙvޚk-=}Z@$㏧= Oj\cwhmnA&~NһFqRSEcfh?1$a/8iԥkY 1އFi^ToGgfQYEPEPEPEPEPg\AZLmjС$Ĺ'.`LrFZfT*j@?ZQ*|jqV)VRVP@o!a}*Ύ  .!nIY>֯A [`.O`0*g4{]*RU9KKYzl}SgGt`0-iS xێN[QwaC34oXo E#ȧr؟0Y9+ڲOwS-ZMݶk7J/- VHbIȬ*kG^{qBq*֗,Q,8*ŋp{|;hxBU\p=qޜSU&jҡxVvo#>FXo|1<=ǢF6|١7R>t؀nSu{}7Hլ3h׳nz,r[hKʋ,9nb4(['^֔B;m}oʖyjM!_ /ejKlxћpi=1΀e+dR"9UJF!緹 η}W|_gD7vKumީƶ>CA?*1w*m4GI<&˻~'Kecm[#$Ԫ\WiG (SkV~m{CڶƑo>@RJT8 0E_IJv_J] ?75Gyst*!(t+8l,ⵀc ɫV2c*8yBM$ї_AZ$O KcҭYCi%đO2LjeQ{E5߁p.nVӤ]2H14KTsrF_#vYaV3v*햙ie ~Jps Э[3I%{5jsi[h!hNwKMH%ٻ_#[gA`-3v*ܚE鋧ZR1^1iOdּ|MմȺ`_Qeqj2Xh^'O]g5x@4 eӭ^GK3D &;8,:on$,q]< ۴+hAġTR:$nH"uߵr,~I׷+FX#!Ojnk2OnŞ ^l.Ǧ:5~MŋGm'AʪJtߩ֯Z鰚ZE\啐OxYCNl,sn0r`#IhP)Վ<3h#Eqr1lҜTlb(RݦZ w1bW ?CmlP(1ޖ}62(PLU(=jG$b꧱ǯ֛9Y~W^VnV=;i|k یi8&Ce E"sZK(oݦ%>aUc,<9uwͲ xUB@53RHC ꓱUzF<(DIQMl>tf$tH_k~!ѭof5~y[CS\8݁wO+NY%IcPl:^Ns֥Տ3}տH=ų+LC[sK"Ln'΢sJZ"9 V] ^+L?άE.s{gnaXV _36=O^=G}WW8ͷJi򿝒kUmFA",z6i{ r}9]+_gGAQ\\i Mq2Ewl tL4ʂɜ=k,gP"[tm1֕*|+_RK}MZ}nlm rp9ʆd|˖h/ olTy}IXqK},mxYc?f?wnk+_wiXzⳒU4F~s}R7C14am?^(SXWI8ޤmM<H2U=OTA05"(T8I`P@PHdڒ. p:u)P(ɭ;^Yg#"5O%1@w,0p9$֠]ZuK$9dsE.z+pϭJ6%r;+{#fƹ%M^]2ŧXWc9ZCTM?QX% ɽG@A{?Km_c^\ZeJQ*s|QsEl,3&Q//+Ԝ\# ^N7VΙw(IEYOWezҴqp0:>xێjs[$cIaVEJ{yK*Km~ڻlRdg沭5K% EiO:KD54+ȹ?6qҒ'{WX.[&K:dI$V,o@y\IY6Ķ,FIN3銭߫O-$$Mˎ0x2oO-%d߇_3rF4M r䬐9Tƣ:--t{]34]McÉ";7*}#,QWM2H f9=hTdJߙRfw:[ȯjQl ԟʁ,[R&UyOXԚMv_B}[{0ƶ/ -? \S|g,Q^e#2mTng[>RCsrHe>A_H&貔 > stream JFIF``C    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222ac" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( *hW0VcS^aDԤk]ǘ_ßzIGs^׷So:"^"Isk~*4\7ʿ\\z.pI-XbsȴWC0pB'\&ω O1kf-#G5Π+憥W\?ոeϥ}ъhT#/3`H*FA-xVmcÒR 9C+ռ9?Q퉼2yW ǧ̩b+eQVz!EPEPEPEPEPEPEPEPEPEPEPEPEPEPEPYm A +s{jMWSѴFA IW P -ZC"v#ڶK.ode:EnFݖv.u0vqu֍lҧQd kH]UQMgͣXȄFީҳ^cEWAEyܓ ZǕZ4YCc08+Lkhjꦵ~>6}!טX0< ocp~>[sI+ ÁY:`k)"8OC ^<15JѠQk H'f9VSz]Պ$ /_Mfѳs N7]`.G&ڼ.X4 ׎{H-5Xu?+yMn##G} 7A-W^M(=`(((((((((((((vH#l qQ]DJ-mSXmʞ_Oozpcc繹fϰG^ n妕YI'~"&?^.P]/ WEQ^9Q@Q@Q@@ak+g ~=ZR)IP閇Yƙ&W! QO RѱC 5EWNCѼCdc{ܧq ~gK^%V+})NZmu+FazAUς>!%o<=;|#ױ^:5=(M((((((((((((s㦮Bz27 Q^_6T79Ku]sVc>Z^{ (u??ּON{? ]ݑ?4Ra濭zy/BeխC+ϧ ( ( ( ( ( >+HJ.kf8ͫjG&><ºwokU4~$mf.IyEdh#K?0zzׯ% rYqJ*NaETQ@Q@P5{mŮn]S 6 ѭa2БJ\-Nv_Y*(U*; 391>-شQEy'QEQEQEQEQEQEQEQEQEQEQEQE|Fyon}:^7ƺ*' ).*QqgvmmkI5/ 7OiTOSVm]);R 2ddNC)+c]?;\~=+:)V[ .jR/藀rm ˷70\(?pʼ2 OnVH'U֖3Cߐ/㏭6e &gov` +\F4vj,x[k؏Pz_[WxIXuH7⽓Xnxm s[N%sm}j2\DtqZ6}&>SiBH H5 =\޵LgEzӼLǕQQ=hVKc8Nz-\4'`;eQ\^5wzX DzX|#l[۲Ākb_jqbUD(r:{}k9/\ס+j{{W?;:A^&;}VQEyGQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEs,^?*?.!|#^'N\f JO3_PSd%цXdEuas筆]>JP#qZP`VgNfD7DO>ڷi,_?^,u)%ئֹ֦u-6O.4LzU<`5:x=j6h? g 312M>q,7>=jk%~Ϥ\i:K\3W}|mQW#ƹCvwdWgmwg[Kq;H'}fGKm)u.|n9#}zנhZ}K>O$kFF>u=hf z+ ( ( ( ( ( ( ( ( ( ( ( ( (q2(3=M: ɫ jkDV³IZ'7(dtEVOQRPQEQEQEQEQEQEQEQEQEQEQETWQm&Ue#*ZlMn N{\H.+Kh8֓ɧYeP;0sVWu.qU LYÆ ⤏>Y{cKZK1#篸#u 02GIJeR?Z>G>(6SBvd;7CusgGAdGm$Gi$M**{]_ijn˘uFX[2ُ9K}/Am]8[1vǧ+rŘsc??G?u*\=F;Rkx^Ns- @=;zya}@H"yB}Jprj?IroO*G'#Cmf5QH@@,OQVb9iJiy|QԾZH%6## o isEj%(FUV` k 1)tQz(hxGmyZB Pѐ!9ϯ\U9Se{6B$FtZ:uդyzAq[aVf  :`${WknejrD0O]h<musxQb{v>?fE&t2Y5;@^+y %y|ex=kRK(tM^-@No<xZ 01w:-QM.*zo :$=QޗQ>]-ꋦF$uA5~!# _\2;p1A>kok\f~ɑߧ'IVrKuUR[44G^ edlU` E7?u[t#mr177 {Yk9m7XJ|~Б=_{~*nI9Y+jDF#(vM9{ 72[F,~ }\s,]b۸[+zⴧE^Qڊ+;FS/ў|M_dn+U;Qլ"f稪:.mX\ݩYܗ3%h"ѯ'yA= ?BQ}Ge+Y^5-.I,[F;ʲ`rSCm224y|.ּ\[+DnAzn/u6ȯ^4! 3ћ!vJ;7vM:*hIdRH*Ե ~#ѷ݁OBK ƽ?gQ֍Oi +#P((((((((/cbFKt o.u k #[ Gtoɧh%Λd)A'>ZhTUhaa^‡AM֏VH_ #rtWȦEX8Rbcxuteo~ԭ~k:mΛwY8"M遏^sZ:=%ӥ[iq1嘶?B)ޛp)kn5Oi}A2ČF}8h'M$d+ǡAR9&Kp-;M>|`Q~WzhC+tٷR$d#h8? WQK,WW߭φuK[\O+J<'9QK;S}b?0 dž)xXX0#0ZÖxk[By?1JTdZ֦N$(Я _[VA, {d OgXDȖʑC\그%t7tx6rƃ\~U+Ð\OMuQQ9E QAETQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEQEPmI{6fn0.Ͻ_mK`) ((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((( endstream endobj 2 0 obj << /ProcSet [/PDF /Text /ImageB /ImageC /ImageI] /Font << /F1 3 0 R /F2 4 0 R >> /XObject <> >> endobj 5 0 obj <> /H /I>> endobj 6 0 obj <> /H /I>> endobj 17 0 obj << /Title (Daiichi Sankyo and AstraZeneca Announce Global Development and Commercialization Collaboration for Daiichi Sankyo s HER2 Targeting Antibody Drug Conjugate [Fam-] Trastuzumab Deruxtecan \(DS-8201\) ) /Author (Daiichi Sankyo) /Subject (Daiichi Sankyo and AstraZeneca Announce Global Development and Commercialization Collaboration for Daiichi Sankyo s HER2 Targeting Antibody Drug Conjugate [Fam-] Trastuzumab Deruxtecan \(DS-8201\) ) /Creator (TCPDF) /Producer (TCPDF 6.2.26 \(http://www.tcpdf.org\)) /CreationDate (D:20191213083123+01'00') /ModDate (D:20191213083123+01'00') /Trapped /False >> endobj 18 0 obj << /Type /Metadata /Subtype /XML /Length 4637 >> stream application/pdf Daiichi Sankyo and AstraZeneca Announce Global Development and Commercialization Collaboration for Daiichi Sankyo’s HER2 Targeting Antibody Drug Conjugate [Fam-] Trastuzumab Deruxtecan (DS-8201) Daiichi Sankyo Daiichi Sankyo and AstraZeneca Announce Global Development and Commercialization Collaboration for Daiichi Sankyo’s HER2 Targeting Antibody Drug Conjugate [Fam-] Trastuzumab Deruxtecan (DS-8201) 2019-12-13T08:31:23+01:00 TCPDF 2019-12-13T08:31:23+01:00 2019-12-13T08:31:23+01:00 TCPDF 6.2.26 (http://www.tcpdf.org) uuid:83ad4acb-1c60-c7b0-0402-3cd09869338f uuid:83ad4acb-1c60-c7b0-0402-3cd09869338f http://ns.adobe.com/pdf/1.3/ pdf Adobe PDF Schema http://ns.adobe.com/xap/1.0/mm/ xmpMM XMP Media Management Schema internal UUID based identifier for specific incarnation of a document InstanceID URI http://www.aiim.org/pdfa/ns/id/ pdfaid PDF/A ID Schema internal Part of PDF/A standard part Integer internal Amendment of PDF/A standard amd Text internal Conformance level of PDF/A standard conformance Text endstream endobj 19 0 obj << /Type /Catalog /Version /1.7 /Pages 1 0 R /Names << >> /ViewerPreferences << /Direction /L2R >> /PageLayout /SinglePage /PageMode /UseNone /OpenAction [7 0 R /FitH null] /Metadata 18 0 R >> endobj xref 0 20 0000000000 65535 f 0000001110 00000 n 0000020716 00000 n 0000001169 00000 n 0000001275 00000 n 0000020842 00000 n 0000021230 00000 n 0000000015 00000 n 0000000489 00000 n 0000001386 00000 n 0000012213 00000 n 0000003735 00000 n 0000003679 00000 n 0000003623 00000 n 0000002638 00000 n 0000003373 00000 n 0000002822 00000 n 0000021446 00000 n 0000022521 00000 n 0000027241 00000 n trailer << /Size 20 /Root 19 0 R /Info 17 0 R /ID [ <83ad4acb1c60c7b004023cd09869338f> <83ad4acb1c60c7b004023cd09869338f> ] >> startxref 27450 %%EOF

Daiichi Sankyo and AstraZeneca Announce Global Development and Commercialization Collaboration for Daiichi Sankyo’s HER2 Targeting Antibody Drug Conjugate [Fam-] Trastuzumab Deruxtecan (DS-8201)

Die Pressemeldungen in englischer Sprache finden Sie hier